ResearchMoz.us include new market research report" Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease" to its huge collection of research reports.
Buy a copy of this report:
http://www.researchmoz.us/sample/checkout.php?rep_id=167419&type=S
Immunoglobulin Market to 2019 provides in-depth analysis of the global
immunoglobulin market. The report analyzes the markets for
immunoglobulin products in the US, the top five European countries (the
UK, Germany, France, Italy and Spain) and Japan. The revenue and annual
cost of therapy are forecast for the key geographies and in seven key
therapeutic segments, along with epidemiology data, until 2019.
The seven key therapeutic segments are Primary Immunodeficiency (PI),
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal
Motor Neuropathy (MMN), Guillain-Barré Syndrome (GBS), Myasthenia Gravis
(MG), Idiopathic Thrombocytopenic Purpura (ITP), and Chronic
Lymphocytic Leukemia (CLL). The report also profiles the marketed
products, key pipeline products, and leading companies that could change
the market landscape in the forecast period.
The report has
been built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GBI
Research’s team of industry experts. GBI Research expects the
immunoglobulin market to see a slight increase in its growth rate during
the 2012–2019 forecast period. It was worth $3.6 billion in 2012,
having grown at a Compound Annual Growth Rate (CAGR) of 6% from 2006.
Demand for immunoglobulin products continues to increase due to growing
disease awareness and therapeutic usage in a wide range of therapeutic
areas. Immunology and neurology are the disciplines that use the most
immunoglobulins, while PI and CIDP are the top indications.
Geographically, the US is the largest market, commanding a share of over
70% of the global market. 11 new products have been approved in the US
since 2006, but as many are for PI or ITP, immunoglobulin usage in the
US remains off-label for all other indications. Baxter, CSL Behring, and
Grifols continue to command the top ranks in terms of revenue, and
recent approvals of Subcutaneous Immunoglobulins (SCIGs) in the US and
Europe will further boost market growth.
Scope
Annualized market data for the immunoglobulin market from 2006 to 2012 and forecast to 2019
Analysis of the seven key therapeutic segments: PI, CIDP, MMN, MG, CLL, GBS and ITP
Analysis of the immunoglobulins markets in the leading global geographies: the US, the top five European countries, and Japan
Market characterization of the immunoglobulin market, covering size,
revenue analysis by geography, annual cost of therapy, and epidemiology
Key drivers and barriers that have a significant impact on the market
Coverage of key marketed products, approved indications, and safety and efficacy profiles
Coverage of the pipeline molecules in various phases of drug development
Competitive profiling of the leading companies: Baxter, Biotest, Bio Products Laboratory, CSL Behring, Grifols, and Octapharma
Key M&A activity and licensing agreements between 2012 and mid-2013 in the global immunoglobulin market
Overview of the immunoglobulin markets in Asia-Pacific and China, covering regulations, key players and marketed products
Reasons to Buy
Align your product portfolio to the markets with high growth potential
Develop market-entry and market-expansion strategies by identifying the
leading therapeutic segments and geographic markets poised for strong
growth
Develop key strategic initiatives by understanding the key focus areas of the leading companies
Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
To Read The Complete Report with TOC Kindly Visit:
http://www.researchmoz.us/immunoglobulins-market-to-2019-demand-in-primary-immunodeficiency-pi-and-chronic-inflammatory-demyelinating-polyneuropathy-cidp-potentially-supplemented-by-approvals-for-alzheimers-disease-report.html For More Information Kindly Contact
Email:
sales@researchmoz.us WebSite:
http://www.researchmoz.us/
